Home

med tid Aska Enastående teva pharmaceuticals quarterly report financial calendar formatera I tid Understrykning

Teva Pharmaceutical Industries Limited 2022 Q2 - Results - Earnings Call  Presentation (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical Industries Limited 2022 Q2 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha

Teva Pharmaceuticals Q2 2019 earnings preview | AlphaStreet
Teva Pharmaceuticals Q2 2019 earnings preview | AlphaStreet

Teva Pharmaceutical (TEVA) Earnings Dates & Reports - TipRanks.com
Teva Pharmaceutical (TEVA) Earnings Dates & Reports - TipRanks.com

Alkermes (ALKS) Down Despite Q3 Earnings & Revenue Beat | Nasdaq
Alkermes (ALKS) Down Despite Q3 Earnings & Revenue Beat | Nasdaq

Teva Pharmaceutical Industries Limited Reports Earnings Results for the  Second Quarter and Six Months Ended June 30, 2023 -August 02, 2023 at 07:13  am EDT | MarketScreener
Teva Pharmaceutical Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 -August 02, 2023 at 07:13 am EDT | MarketScreener

Teva Recalls One Lot Of IDArubicin Hydrochloride Injection
Teva Recalls One Lot Of IDArubicin Hydrochloride Injection

Teva Reports First Quarter 2021 Financial Results | Business Wire
Teva Reports First Quarter 2021 Financial Results | Business Wire

Teva Pharmaceutical Industries Earnings Date and Reports 2023 (NYSE:TEVA)
Teva Pharmaceutical Industries Earnings Date and Reports 2023 (NYSE:TEVA)

Teva Q2 Earnings: 5 Reasons Why Shares Rose By 30% (NYSE:TEVA) | Seeking  Alpha
Teva Q2 Earnings: 5 Reasons Why Shares Rose By 30% (NYSE:TEVA) | Seeking Alpha

Teva Reports Third Quarter 2022 Financial Results
Teva Reports Third Quarter 2022 Financial Results

Teva to Cut Up to 25% of Israel Workforce, Calcalist Says - Bloomberg
Teva to Cut Up to 25% of Israel Workforce, Calcalist Says - Bloomberg

Teva Pharmaceutical (TEVA) Earnings Dates & Reports - TipRanks.com
Teva Pharmaceutical (TEVA) Earnings Dates & Reports - TipRanks.com

Teva Stock Plunges On Flat Sales, Earnings Disappointment | Investor's  Business Daily
Teva Stock Plunges On Flat Sales, Earnings Disappointment | Investor's Business Daily

Teva Pharmaceutical Industries Limited 2022 Q2 - Results - Earnings Call  Presentation (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical Industries Limited 2022 Q2 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha

eToro Earnings Reports Calendar
eToro Earnings Reports Calendar

Teva Pharmaceutical, Marathon Oil And 2 Other Stocks Insiders Are Selling -  Kraft Heinz (NASDAQ:KHC), Marathon Oil (NYSE:MRO) - Benzinga
Teva Pharmaceutical, Marathon Oil And 2 Other Stocks Insiders Are Selling - Kraft Heinz (NASDAQ:KHC), Marathon Oil (NYSE:MRO) - Benzinga

Teva ADR earnings beat by $0.03, revenue topped estimates - Investing.com  India
Teva ADR earnings beat by $0.03, revenue topped estimates - Investing.com India

DEF 14A
DEF 14A

Teva Pharmaceutical Is in Recovery - WSJ
Teva Pharmaceutical Is in Recovery - WSJ

Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha

Teva Pharmaceutical Industries Ltd. - Investors
Teva Pharmaceutical Industries Ltd. - Investors

Teva partnership with Sanofi 'will pay dividends,' analyst says -  MarketWatch
Teva partnership with Sanofi 'will pay dividends,' analyst says - MarketWatch

Teva Pharma hoping for Q2 recovery after Q1 EPS disappointment | Seeking  Alpha
Teva Pharma hoping for Q2 recovery after Q1 EPS disappointment | Seeking Alpha

Earnings Scheduled For February 8, 2023 - Trimble (NASDAQ:TRMB), Teva  Pharmaceutical Indus (NYSE:TEVA) - Benzinga
Earnings Scheduled For February 8, 2023 - Trimble (NASDAQ:TRMB), Teva Pharmaceutical Indus (NYSE:TEVA) - Benzinga

Teva Pharmaceutical Industries Ltd. - Investors
Teva Pharmaceutical Industries Ltd. - Investors

Teva's Strategic Evaluation: Israeli Pharma Company Mulls Divesting $2B  Active Ingredients Unit - Teva Pharmaceutical Indus (NYSE:TEVA) - Benzinga
Teva's Strategic Evaluation: Israeli Pharma Company Mulls Divesting $2B Active Ingredients Unit - Teva Pharmaceutical Indus (NYSE:TEVA) - Benzinga

Teva Reports Fourth Quarter and Full Year 2019 Financial Results | Business  Wire
Teva Reports Fourth Quarter and Full Year 2019 Financial Results | Business Wire

Infographic: Teva Pharmaceuticals (TEVA) Q1 2021 earnings results |  AlphaStreet
Infographic: Teva Pharmaceuticals (TEVA) Q1 2021 earnings results | AlphaStreet